MedVellum
MedVellum
Back to Library

Lithium Toxicity

On This Page

Overview

Lithium Toxicity

Quick Reference

Critical Alerts

  • Chronic toxicity is more dangerous than acute overdose at same serum level
  • Neurological symptoms are the hallmark of severe toxicity
  • Hemodialysis is the definitive treatment for severe toxicity
  • Rebound phenomenon occurs - repeat dialysis often needed
  • Watch for nephrogenic diabetes insipidus - common complication

Key Diagnostics

  • Serum lithium level (therapeutic 0.6-1.2 mEq/L)
  • BMP (sodium, creatinine - critical for context)
  • Serial lithium levels (every 2-4 hours until declining)
  • ECG (conduction abnormalities)
  • TSH (chronic effects)

Emergency Treatments

  • IV fluids: Normal saline for volume depletion
  • Avoid NSAIDs, ACE inhibitors, thiazides: Increase lithium levels
  • Whole bowel irrigation: For sustained-release formulations
  • Hemodialysis: Severe neurological symptoms, level >4 mEq/L
  • Supportive care: Airway protection if needed

Definition

Lithium toxicity is a potentially life-threatening condition resulting from elevated lithium levels, either from acute ingestion or chronic accumulation. Lithium has a narrow therapeutic index, making toxicity relatively common among patients on chronic therapy.

Types of Lithium Toxicity

TypeDescriptionKey Features
AcuteSingle large ingestionGI symptoms early, neuro later; higher levels tolerated
Acute-on-chronicAcute ingestion on chronic therapyIntermediate severity
ChronicGradual accumulation on therapyMore severe at lower levels; insidious onset

Therapeutic vs Toxic Levels

Level (mEq/L)Interpretation
0.6-1.2Therapeutic range
1.5-2.5Mild-moderate toxicity
2.5-3.5Moderate-severe toxicity
>.5Severe toxicity (life-threatening)

Important: Clinical status matters more than level alone, especially in chronic toxicity

Epidemiology

  • Prevalence of toxicity: 25% of lithium-treated patients experience toxicity
  • Common triggers: Dehydration, drug interactions, renal impairment
  • Mortality: <1% with appropriate treatment

Pathophysiology

Pharmacokinetics

ParameterValue
AbsorptionComplete; peak 1-2 hours (immediate-release), 4-6 hours (sustained-release)
DistributionTotal body water; concentrates in CNS over time
Protein bindingNone
MetabolismNone (excreted unchanged)
EliminationRenal (95%); half-life 18-36 hours; prolonged in toxicity

Mechanism of Toxicity

Cellular Effects

  • Competes with sodium, potassium, magnesium, calcium
  • Inhibits adenylyl cyclase (reduces cAMP)
  • Affects inositol phosphate signaling
  • Alters neurotransmitter release
  • Disrupts thyroid and renal function

Why Chronic Toxicity Is Worse

  • Time for tissue distribution (especially CNS)
  • At steady state, tissues equilibrated with plasma
  • Lower plasma levels still reflect high tissue levels
  • Acute overdose: high plasma, low tissue initially

Factors Precipitating Toxicity

FactorMechanism
DehydrationReduced renal clearance
Sodium depletionIncreased renal lithium reabsorption
NSAIDsReduce GFR, increase lithium reabsorption
ACE inhibitors/ARBsReduce GFR
Thiazide diureticsIncrease lithium reabsorption
Loop diureticsLess effect, but volume depletion matters
Acute kidney injuryReduced elimination
Infection/feverDehydration
Heart failureReduced renal perfusion

Clinical Presentation

Symptoms by System

Gastrointestinal (Early, Especially Acute)

Neurological (Hallmark of Toxicity)

SeveritySymptoms
MildTremor (fine), lethargy, weakness
ModerateCoarse tremor, ataxia, slurred speech, confusion, fasciculations
SevereComa, seizures, myoclonus, choreoathetosis

Cardiovascular

Renal

Endocrine

Clinical Grading

GradeFeatures
MildTremor, GI symptoms, mild lethargy
ModerateConfusion, ataxia, dysarthria, fasciculations
SevereComa, seizures, cardiovascular instability

SILENT Mnemonic for Chronic Toxicity


Nausea, vomiting
Common presentation.
Diarrhea
Common presentation.
Abdominal cramps
Common presentation.
Red Flags (Life-Threatening)

Critical Findings

Red FlagConcernAction
Altered mental statusSevere CNS toxicityICU, hemodialysis
SeizuresSevere toxicityBenzodiazepines, hemodialysis
Level > mEq/LLife-threateningEmergent hemodialysis
Chronic toxicity with level >.5Established tissue distributionHemodialysis
Hemodynamic instabilityCardiovascular toxicityICU, supportive care
Rising lithium levelOngoing absorptionExtended WBI
Irreversible neurological damageSILENT syndromeMay persist despite treatment

SILENT Syndrome

Syndrome of Irreversible Lithium-Effectuated Neurotoxicity

  • Persistent cerebellar dysfunction
  • Cognitive impairment
  • Basal ganglia dysfunction
  • May occur despite appropriate treatment
  • More common with delayed treatment or chronic toxicity

Differential Diagnosis

Conditions Mimicking Lithium Toxicity

ConditionDistinguishing Features
Serotonin syndromeHyperthermia, hyperreflexia, medication history
NMSRigidity, hyperthermia, antipsychotic use
Thyroid stormHyperthyroidism, fever, tachycardia
EncephalitisFever, CSF abnormalities
StrokeFocal neurological findings, imaging
Metabolic encephalopathyElectrolyte abnormalities, liver/renal failure
Other drug toxicitySpecific levels, toxidrome

Causes of Tremor in Psychiatric Patients

  • Lithium therapeutic effect (fine tremor)
  • Lithium toxicity (coarse tremor)
  • Antipsychotic-induced parkinsonism
  • Valproate tremor
  • Essential tremor
  • Caffeine/stimulant use

Diagnostic Approach

Initial Assessment

Key History

  • Lithium dose and formulation (immediate vs sustained-release)
  • Time since last dose or overdose
  • Acute vs chronic ingestion
  • Recent changes in medications
  • Dehydration, illness, sodium intake
  • Symptoms and timeline

Laboratory Studies

TestPurposeCritical Values
Serum lithiumDiagnosis>1.5 concerning; > severe
BMPSodium, renal functionHyponatremia, elevated Cr
CalciumMay be affected
TSHHypothyroidism
ECGConduction abnormalitiesT-wave changes, QT prolongation
UrinalysisUrine output, concentrationDilute in DI

Serial Lithium Levels

Essential for Management

  • Draw every 2-4 hours
  • Continue until clearly declining
  • Sustained-release: Peak may be delayed 12+ hours
  • Post-dialysis: Recheck at 6 hours (rebound)

Level Interpretation

ScenarioLevelImplication
Acute OD, asymptomatic2.5May observe with hydration
Chronic, mild symptoms1.5-2.0May be significant; treat
Chronic, severe symptoms2.5Hemodialysis indicated
Any, altered mental statusAny elevatedHemodialysis indicated

Treatment

Initial Management

Volume Resuscitation

Normal saline bolus then maintenance
- Restores renal perfusion
- Enhances lithium clearance
- Corrects sodium depletion

Avoid:
- Sodium bicarbonate (no benefit)
- Forced diuresis with diuretics (no benefit, may harm)

GI Decontamination

Activated Charcoal

  • Does NOT bind lithium
  • Not recommended for isolated lithium ingestion

Whole Bowel Irrigation

Indication: Sustained-release lithium, significant ingestion
Solution: Polyethylene glycol electrolyte solution
Rate: 1-2 L/hour via NG until effluent clear
Contraindications: Ileus, obstruction, altered mental status without airway protection

Enhanced Elimination

Hemodialysis (Definitive Treatment)

IndicationDetails
Level > mEq/LRegardless of symptoms
Severe symptomsSeizures, altered consciousness
Chronic toxicity with level >.5 and symptomsTissue distribution established
Impaired renal functionUnable to clear lithium
Symptoms not improving with supportive careClinical deterioration

Hemodialysis Parameters

Modality: Intermittent HD preferred (more efficient)
Duration: 4-6 hours typically
Expect: Rapid level decline during HD
Watch for: Rebound (levels rise 6+ hours post-HD)
Repeat HD: Often needed for rebound
CRRT: Use if hemodynamically unstable

Post-Dialysis Monitoring

  • Recheck lithium level 6 hours post-HD
  • Repeat HD if level rebounds >3 or symptoms return
  • May need multiple sessions

Supportive Care

IssueManagement
SeizuresBenzodiazepines
Airway protectionIntubation if GCS impaired
HypotensionIV fluids, vasopressors rarely needed
Nephrogenic DIFree water access, may need desmopressin
HypothyroidismCheck TSH, treat if indicated

Stop Offending Medications

Discontinue or Avoid

  • NSAIDs
  • ACE inhibitors/ARBs
  • Thiazide diuretics
  • Any cause of dehydration

Disposition

ICU Admission Criteria

  • Altered mental status
  • Seizures
  • Severe toxicity requiring hemodialysis
  • Hemodynamic instability
  • Need for airway protection

Monitored Bed Admission

  • Moderate toxicity with neurological symptoms
  • Elevated level requiring serial monitoring
  • Unclear whether acute or chronic

Observation

  • Acute ingestion, asymptomatic, mildly elevated level
  • Normal renal function
  • Access to serial levels

Discharge Criteria

  • Asymptomatic
  • Lithium level declining and <1.5 mEq/L
  • Stable renal function
  • Cause of toxicity identified and addressed
  • Psychiatric assessment if intentional
  • Follow-up arranged for lithium level and clinical status

Patient Education

Understanding Lithium

  • Lithium is an effective medication for bipolar disorder
  • It has a very narrow safety margin
  • Many factors can affect lithium levels
  • Regular blood monitoring is essential

Preventing Future Toxicity

Medication Safety

  • Take lithium exactly as prescribed
  • Do not change dose without physician guidance
  • Maintain consistent salt and fluid intake
  • Avoid dehydration (illness, exercise, hot weather)

Drug Interactions to Avoid

  • NSAIDs (ibuprofen, naproxen)
  • Do not start new medications without checking with physician/pharmacist

Warning Signs

  • Increased thirst or urination
  • Tremor worsening
  • Nausea, vomiting, diarrhea
  • Confusion, slurred speech
  • Muscle weakness

Regular Monitoring

  • Lithium levels as directed
  • Kidney function tests
  • Thyroid function tests

Special Populations

Elderly Patients

  • More susceptible to toxicity
  • Reduced renal function with age
  • More sensitive to neurological effects
  • Start at lower doses
  • More likely to have drug interactions

Pregnancy

  • Lithium associated with cardiac malformations (Ebstein's anomaly)
  • Continue only if benefits outweigh risks
  • Switch to alternative if possible in first trimester
  • Levels decrease during pregnancy; increase postpartum
  • Hemodialysis safe in pregnancy if indicated

Renal Impairment

  • Reduced lithium clearance
  • Requires dose adjustment
  • More frequent monitoring
  • Lower threshold for toxicity
  • May need chronic renal replacement if caused by lithium

Intentional Overdose

  • Psychiatric evaluation required
  • May have additional ingestions
  • Thorough toxicological workup
  • Suicide risk assessment

Quality Metrics

Performance Indicators

MetricTarget
Serum lithium level obtained100%
BMP obtained100%
Serial lithium levels ordered100% of significant elevations
Hemodialysis initiated if indicatedWithin 4-6 hours
Nephrology consultation for HD criteria100%
Psychiatric consultation (intentional)100%

Documentation Requirements

  • Type of exposure (acute, chronic, acute-on-chronic)
  • Formulation (immediate vs sustained-release)
  • Time of ingestion
  • Serial lithium levels with times
  • Clinical status at each level
  • Treatment provided
  • Dialysis details if performed
  • Disposition rationale

Key Clinical Pearls

Diagnostic Pearls

  1. Chronic toxicity is more dangerous at same serum level
  2. Neurological exam is critical - level alone doesn't predict severity
  3. Sustained-release peaks late - repeat levels beyond 12 hours
  4. Look for the precipitant - dehydration, drugs, renal impairment
  5. Expect rebound after hemodialysis - recheck at 6 hours

Treatment Pearls

  1. Charcoal does not bind lithium - don't use it
  2. WBI for sustained-release - may have ongoing absorption
  3. Normal saline first - restore volume and sodium
  4. Hemodialysis is definitive for severe toxicity
  5. Multiple dialysis sessions often needed

Disposition Pearls

  1. ICU for any significant neurological symptoms
  2. Serial levels until declining - don't d/c on single level
  3. Address the cause - change meds, patient education
  4. Psychiatric consult if intentional overdose
  5. Close follow-up - reinitiate lithium carefully if needed

References
  1. Decker BS, et al. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol. 2015;10(5):875-887.
  2. Baird-Gunning J, et al. Lithium poisoning. J Intensive Care Med. 2017;32(4):249-263.
  3. Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol. 1999;10(3):666-674.
  4. Ott M, et al. Lithium intoxication: Incidence, clinical course and renal function. BMC Psychiatry. 2016;16:60.
  5. Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible lithium-effectuated neurotoxicity. Clin Neuropharmacol. 2005;28(1):38-49.
  6. Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4(1):27.

Version History
VersionDateChanges
1.02025-01-15Initial comprehensive version with 14-section template

At a Glance

EvidenceStandard
Last UpdatedRecently

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines